ClinicalTrials.gg
RecruitingNCT05533138Updated Jun 25, 2024

Internet CBT for Antenatal Depression

An interventional study of Therapist Guided Internet-CBT for antenatal depression and Therapist Guided Internet-CBT for antenatal depression and perinatal extra support. in Antenatal Depression, sponsored by Karolinska Institutet. Recruiting at 1 site in Sweden. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-25.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 4 months after the study started (first participant enrolled Feb 2021, registered Jun 2022).
  • Started Feb 2021; still recruiting 5 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
415
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 42 studies in Depression by Karolinska Institutet — 8 open to participants now, 11 under way, none of them phase 3. Depression · Karolinska Institutet.

Planned enrollment
4th of 34
415 · median 130
Started
2021
with 3 others
No phase
31 of 42
5 open now
Primary completion
2025-12
later than 3 of 10 live
Registered
27th of 42
by date

Among the 42 studies in Depression by Karolinska Institutet, this one is the 4th largest by planned enrollment of the 34 interventional ones that give a count, is one of 4 that started in 2021, is one of 31 with no phase, reaches primary completion later than 3 of the 10 other live ones, and was the 27th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

8 of the 42 studies in Depression by Karolinska Institutet are open now, in 1 country. Recruiting first, the newest first:

2 more — sign in →

By country, each count listing its studies:

All 8 open studies →

Where they have run

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 42 studies in Depression by Karolinska Institutet, or all of them as a file.
02

Study summary

Pregnant women in pregnancy week 8-29 screening positive for antenatal depression will be randomized to either choose or to be allotted by chance to different forms of diagnostic assessment; i.e. telephone, video or face-to-face assessment.

Those diagnosed with mild to moderate major depression will then be randomized to treatment with therapist-guided Internet-delivered Cognitive Behavioral Therapy (ICBT) adapted for women suffering from antenatal depression or to the same treatment with addition of up to three contacts with extra support by a midwife or experienced perinatal mental health nurse.

The primary aim is to assess whether extrasupport in addition to internet-guided pregnancy adapted ICBT decreases depressive symptoms more than internet-guided pregnancy adapted ICBT only. Secondary aims include effects of extrasupport and assessment mode on treatment satisfaction, fidelity and credibility.

03

Conditions studied

  • Antenatal Depression

Browse trials for

Keywords

  • Cognitive behavior therapy
  • Internet treatment
  • Self-help treatment
  • Perinatal support
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mild to moderate major depression
  • Pregnant at treatment start
  • Regular contact with maternity mental health clinic
  • > 18 years old
  • Being able to start the treatment earliest in gestational week 8 and latest in gestational week 30
  • Stable medication for depression and/or other psychiatric conditions for at least 3 weeks.
  • Being able to participate in the treatment during the treatment time and having access to and being able to use the internet and mobile phone during the treatment time
  • Being able to understand the Swedish language orally and in writing

Exclusion criteria

Exclusion Criteria:

  • Montgomery-Åsberg Depression Rating Scale-Self report version (MADRS-S) score below 15 (symptoms of depression to low) or above 35 (severe depression)
  • High risk of self harm or suicide (based on semi-structured clinical suicide risk assessment)
  • Psychiatric comorbidity, disability, somatic disorder, or pregnancy complications that prevent treatment participation or that can be negatively affected or compose a risk for the fetus by treatment participation
  • Ongoing psychological treatment with similar content
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
415 participants (estimated)

Study arms

  • Active comparator
    Assessment form allocated by chance & guided ICBT for antenatal depression

    Patients are randomized to assessment modality (telephone, video or face-to-face visit) of a perinatal psychiatric semi-structured assessment \& and are randomised to treatment with internet-CBT for antenatal depression without extra-support (10 weeks)

    Behavioral: Therapist Guided Internet-CBT for antenatal depression · Behavioral: Diagnostic assessment by telephone, video or face-to face - Allocation by chance

  • Active comparator
    Assessment form allocated by choice & guided ICBT for antenatal depression

    Patients choose assessment modality (telephone, video or face-to-face visit) of a perinatal psychiatric semi-structured assessment \& are randomised to treatment with internet-CBT for antenatal depression without extra-support (10 weeks)

    Behavioral: Therapist Guided Internet-CBT for antenatal depression · Behavioral: Diagnostic assessment by telephone, video or face-to face - Allocation by choice

  • Experimental
    Assessment form allocated by chance & guided ICBT for antenatal depression with extra support

    Patients are randomized to assessment modality (telephone, video or face-to-face visit) of a perinatal psychiatric semi-structured assessment \& and are randomised to treatment with internet-CBT for antenatal depression with extra-support

    Behavioral: Therapist Guided Internet-CBT for antenatal depression and perinatal extra support. · Behavioral: Diagnostic assessment by telephone, video or face-to face - Allocation by chance

  • Experimental
    Assessment form allocated by choice & guided ICBT for antenatal depression with extra support

    Patients choose assessment modality (telephone, video or face-to-face visit) of a perinatal psychiatric semi-structured assessment \& are randomised to treatment with internet-CBT for antenatal depression with extra-support (10 weeks)

    Behavioral: Therapist Guided Internet-CBT for antenatal depression and perinatal extra support. · Behavioral: Diagnostic assessment by telephone, video or face-to face - Allocation by choice

Interventions

  • BehavioralTherapist Guided Internet-CBT for antenatal depression

    A 10 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for depression adapted for antenatal depression.

  • BehavioralTherapist Guided Internet-CBT for antenatal depression and perinatal extra support.

    A 10 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet. Includes traditional CBT-methods for depression adapted for antenatal depression. Additionally, up to three supportive contacts with a midwife or perinatal mental health nurse to support ICBT treatment and adress general pregnancy related health problems.

  • BehavioralDiagnostic assessment by telephone, video or face-to face - Allocation by chance

    Structured diagnostic perinatal psychiatric assessment of women screening positive for antenatal depression (pregnancy week 8-29) by telephone, video or in a face-to-face meeting. Assessment form allocation by chance.

  • BehavioralDiagnostic assessment by telephone, video or face-to face - Allocation by choice

    Structured diagnostic perinatal psychiatric assessment of women screening positive for antenatal depression (pregnancy week 8-29) by telephone, video or in a face-to-face meeting. Assessment form allocation based on patient preference.

06

What researchers measure

Primary outcomes

  1. Change in Montgomery Asberg Depression Rating Scale, self-rating version (MADRS-S)

    A 9-item self-rated measure of depression severity that also screens for suicidality (Montgomery \& Asberg, 1979). Scores range from 0 to 54 points with 13-19 points indicating mild depression, 20-34 points indicating moderate depression and 35-54 points indicating severe depression

    Time frame: Baseline to post-treatment (10 weeks) and to 8-10 weeks post-partum

Secondary outcomes

  1. Change in Edinburgh Postnatal Depression Scale (EPDS)

    Self-rated measure of antenatal depression (Cox, Holden \& Sagovsky, 1987) used for screening of perinatal depression and also as a severity measure. Scores range from 0 to 30 with 13 or more points being the cut off for depression during pregnancy. This scale is validated for Swedish pregnant women (Rubertsson et al., 2011).

    Time frame: Baseline to post-treatment (10 weeks) and to 8-10 weeks post-partum

  2. Remission of major depression (DSM-5)

    Diagnostic assessment of major depression assessed by clinician in the same way as before treatment with the depression module of the SCID-I diagnostic interview based on DSM-5 (Spitzer et al., 1992).

    Time frame: Post-treatment (10 weeks)

  3. Remission of major depression (DSM-5)

    Diagnostic assessment of major depression assessed by clinician in the same way as before treatment with the depression module of the SCID-I diagnostic interview based on DSM-5 (Spitzer et al., 1992).

    Time frame: 8-10 weeks postpartum.

  4. Change in Generalized Anxiety Disorder-7 (GAD-7)

    7-item self-assessment measure of symptoms of anxiety and worry (Spitzer et al., 2006). Scores range from 0 to 21 points with 10 points and above indicating clinical levels.

    Time frame: Screening to post-treatment (10 weeks) and to 8-10 weeks post-partum

  5. Change in self-rated Insomnia Severity Index (ISI)

    7-item, self-rated questionnaire measuring perceived severity of insomnia symptoms (Bastien, Vallières \& Morin, 2001). Validated as an outcome measure for insomnia research. The scale includes seven items, scored on a 0-4 scale, that are summed to a range of 0-28. The score can be divided into four categories: no clinical insomnia (0-7), subthreshold insomnia (8-14), clinical insomnia of moderate severity (15-21) and severe clinical insomnia (22-28) (Sarsour et al., 2010).

    Time frame: Baseline to post-treatment (10 weeks) and to 8-10 weeks post-partum

  6. Change in Work and Social Adjustment Scale (WSAS)

    Self-rated measure of level of impairment caused by a condition (Mundt et al. 2002). In this study two versions are used asking about impairment due to depression and due to pregnancy. Scores range from 0 to 40 with scores below 10 points indicating sub clinical impairment and scores above 20 indicating moderately severe impairment or worse.

    Time frame: Baseline to post-treatment (10 weeks) and to 8-10 weeks post-partum

  7. Change in Euroqol (EQ-5D-5L)

    Self-assessed, health related, quality of life questionnaire. 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression (Hinz et al., 2014).

    Time frame: Screening to post-treatment (10 weeks) and to 8-10 weeks post-partum

  8. Change in Prenatal Attachment Inventory (PAI)

    Self-rated measurement of attachment and mentalisation from the mother to the unborn child (Muller 1993; Pallant et al., 2014). 21-items scored on a 1-4 scale.

    Time frame: Screening to post-treatment (10 weeks)

  9. Change in Experience of close relationships (ENR)

    Self-reported measurement of adult attachment style (Brennon et al., 1998; Fraley et al., 2000; Strand \& Ståhl, 2008). 36 items scored on a 1-7 scale.

    Time frame: Screening to 8-10 weeks post-partum

  10. Change in Valentine Scale

    7 item self-rated scale for measurement of satisfaction with the partner relationship (Burman et al., 2018). Range 0-21 with higher values indicating higher partner relationship satisfaction.

    Time frame: Screening to 8-10 weeks post-partum

  11. Change in Fear of birth scale (FOBS)

    Self-assessment of fear and worry in relation to the approaching birth using two visual analogue scales (VAS)(Haines et al., 2015) with higher levels indicating increased fear and worry. Also used to assess fear and worry in relation to completed birth after delivery.

    Time frame: Screening to post-treatment (after 10 weeks) and to 8-10 weeks post-partum

  12. Change in Multidimensional Scale of Perceived Social Support (MSPSS)

    Measures self-rated perceived social support (Zimet et al., 1988; Ekbäck et al., 2013). 12 items rated on a seven-point Likert-type response format (1 = very strongly disagree; 7 = very strongly agree). Range 12 to 84, with higher scores indicating higher perceived social support.

    Time frame: Screening to 8-10 weeks post-partum

  13. Change in Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry (TIC-P)

    Measures healthcare consumption and productivity loss in patients with a psychiatric disorder (Bouwmans et al., 2013).

    Time frame: Baseline to post-treatment (10 weeks) and to 8-10 weeks post-partum

  14. Change in Clinical Global Impression Severity Scale (CGI-S)

    7-item observer-rated scale that measures illness severity (CGI-S) (Guy 1976)

    Time frame: Post-assessment and post treatment (after week 10).

  15. Change in Clinical Global clinical global improvement (CGI-I)

    7-item observer-rated scale that measures global improvement (CGI-I) (Guy 1976).

    Time frame: Post-assessment and post treatment (after week 10).

Other outcomes

  1. Assessment of childbirth experience - The Childbirth experience scale (CEQ)

    Measures the childbirth experience (Dencker et al., 2010) on a 22-item 4-point Likert scale assessing agreement with positive and negative statements ranging from 1 (Totally agree), 2 (Mostly agree), 3 (Mostly disagree) to 4 (Totally disagree).

    Time frame: 8-10 weeks post-partum

  2. Assessment of maternal bonding - Mother-to Infant-Bonding-Scale (S-MIBS)

    Assesses maternal bonding with the infant during the postpartum period. Eight items ranging 0- 3 with higher values indicating more bonding challenges (Taylor et al. 2005, Morelius et al., 2020).

    Time frame: 8-10 weeks post-partum

  3. Assessment of Adverse events

    Patient rated adverse events.

    Time frame: Treatment week 2,4,6,8

  4. Assessment of Adverse events

    Patient rated adverse events.

    Time frame: Post-treatment (10 weeks)

  5. Assessment of Adverse events

    Patient rated adverse events.

    Time frame: 8-10 weeks post-partum

  6. Assessment of Adverse events

    Clinician rated adverse events.

    Time frame: Post-treatment (10 weeks).

  7. Assessment of treatment satisfaction - Client Satisfaction Questionnaire-8 (CSQ-8)

    Measures self-rated satisfaction with treatment with scores from 8 to 32 where 8-13 indicates poor, 14-19 fair, 20-25 good and 26-32 excellent satisfaction (Attkisson and Zwick, 1982; Smith et al. 2014)

    Time frame: Post-treatment (10 weeks)

  8. Assessment of treatment satisfaction - Client Satisfaction Questionnaire-8 (CSQ-8)

    Measures self-rated satisfaction with treatment with scores from 8 to 32 where 8-13 indicates poor, 14-19 fair, 20-25 good and 26-32 excellent satisfaction (Attkisson and Zwick, 1982; Smith et al. 2014)

    Time frame: 8-10 weeks postpartum

  9. Assessment of treatment credibility - Treatment Credibility Scale (TCS)

    The Treatment Credibility Scale is a version of the credibility/expectancy questionnaire (Devilly and Borkovec, 2000) assessing how well the respondent thinks the treatment would work for similar problems. Scores range from 5 to 50.

    Time frame: Treatment week 2

  10. Assessment of treatment credibility - Treatment Credibility Scale (TCS)

    The Treatment Credibility Scale is a version of the credibility/expectancy questionnaire (Devilly and Borkovec, 2000) assessing how well the respondent thinks the treatment would work for similar problems. Scores range from 5 to 50.

    Time frame: Treatment week 4

  11. Assessment of treatment fidelity

    Clinician rated structured assessment with instrument developed at the clinic for internet psychiatry.

    Time frame: Post-treatment (10 weeks)

  12. Assessment of maternity health care, birth- and child related health and care outcomes - Swedish pregnancy and medical birth registers.

    Register data from the Swedish pregnancy and Medical Birth registers regering data on demographic, material health care, delivery care and child related outcomes will be linked by means of the unique personal identification number.

    Time frame: Pregnancy to 8-10 weeks postpartum

  13. Assessment of empowerment

    Patient rated empowerment rated with the 28-item "Empowerment Scale" (Rogers et al. 1997).

    Time frame: Post-assessment, post treatment (after week 10) and 8-10 weeks postpartum

07

Study locations

1 of 1 sites recruiting
  • Psychiatry Southwest, Department of CL Psychiatry & Internetpsychiatry
    Stockholm, 141 86, Sweden
    Recruiting
08

References and documents

Publications

  • Forsell E, Bendix M, Hollandare F, Szymanska von Schultz B, Nasiell J, Blomdahl-Wetterholm M, Eriksson C, Kvarned S, Lindau van der Linden J, Soderberg E, Jokinen J, Wide K, Kaldo V. Internet delivered cognitive behavior therapy for antenatal depression: A randomised controlled trial. J Affect Disord. 2017 Oct 15;221:56-64. doi: 10.1016/j.jad.2017.06.013. Epub 2017 Jun 13. PubMed 28628768 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2021 (actual). Primary completion is estimated for Dec 2025, 58 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 58 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2022
First posted
Sep 8, 2022
StartActual
Feb 25, 2021
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2027
Last update
Jun 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05533138
Collaborators
Region Stockholm
Responsible party
Marie Bendix (Principal investigator, Karolinska Institutet) — Principal investigator
First posted
Sep 8, 2022
Start date
Feb 25, 2021
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Jun 25, 2024

Study contacts

Marie Bendix, PhD
Contact
marie.bendix@ki.se
+46 73 6370 864
Marie Bendix, PhD
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion